Pfizer (PFE) Goodwill & Intangibles (2016 - 2025)
Historic Goodwill & Intangibles for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $120.4 billion.
- Pfizer's Goodwill & Intangibles fell 632.49% to $120.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 billion, marking a year-over-year decrease of 632.49%. This contributed to the annual value of $123.9 billion for FY2024, which is 659.09% down from last year.
- As of Q3 2025, Pfizer's Goodwill & Intangibles stood at $120.4 billion, which was down 632.49% from $121.7 billion recorded in Q2 2025.
- In the past 5 years, Pfizer's Goodwill & Intangibles ranged from a high of $132.7 billion in Q4 2023 and a low of $74.4 billion during Q4 2021
- Moreover, its 5-year median value for Goodwill & Intangibles was $93.5 billion (2023), whereas its average is $101.4 billion.
- Per our database at Business Quant, Pfizer's Goodwill & Intangibles crashed by 1655.2% in 2021 and then surged by 4134.45% in 2024.
- Quarter analysis of 5 years shows Pfizer's Goodwill & Intangibles stood at $74.4 billion in 2021, then rose by 27.42% to $94.7 billion in 2022, then skyrocketed by 40.04% to $132.7 billion in 2023, then fell by 6.59% to $123.9 billion in 2024, then fell by 2.83% to $120.4 billion in 2025.
- Its Goodwill & Intangibles was $120.4 billion in Q3 2025, compared to $121.7 billion in Q2 2025 and $122.4 billion in Q1 2025.